Published in Catheter Cardiovasc Interv on December 02, 2013
Rebuttal: Use of embolic protection devices in saphenous vein graft interventions: the ongoing challenge. Catheter Cardiovasc Interv (2011) 0.75
Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial. Catheter Cardiovasc Interv (2010) 3.24
[Corrected QT interval prolongation: a new predictor of cardiovascular risk in patients with non-ST-elevation acute coronary syndrome]. Rev Esp Cardiol (2008) 2.06
Comparative study of ambient air particles in patients hospitalized for heart failure and acute coronary syndrome. Rev Esp Cardiol (2011) 1.97
Microvascular Function in Ischemic Heart Disease: There May Be Room for Improvement. JACC Cardiovasc Interv (2016) 1.70
Prostate-specific antigen kallikrein is not a marker of non-ST elevation acute coronary syndrome. Int J Cardiol (2011) 1.39
Annual summary 2010: bibliometric data, activities, and new production of the journal. Rev Esp Cardiol (2010) 1.39
On-site immediate removal of intraortic balloon pump after high-risk percutaneous intervention with a 6 F closure suture device with the "preclosure" technique. Catheter Cardiovasc Interv (2007) 1.39
Unplanned redundant publication: a consequence of too many cardiovascular journals? EuroIntervention (2010) 1.39
Are prostate-specific antigen levels predictors of acute coronary syndrome or atrial fibrillation? Int J Cardiol (2012) 1.38
C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J (2004) 1.35
Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X. Eur Heart J (2003) 1.23
Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation (2004) 1.14
Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol (2004) 1.09
Intracoronary abciximab and local anti-inflammatory effects. Int J Cardiol (2013) 1.08
Has Prasugrel Been Compared Correctly With Clopidogrel in Non-ST-Segment Elevation Acute Coronary Syndrome? J Am Coll Cardiol (2015) 1.08
Transcatheter Aortic Valve Replacement: Still in the Way of Learning. J Invasive Cardiol (2016) 1.06
The Role of Drug-Eluting Balloons in Bifurcations: The Remaining Variable to Fit the Perfect Equation. JACC Cardiovasc Interv (2015) 1.06
Severe coronary disease not amenable to revascularization: are the series clearly defined? Catheter Cardiovasc Interv (2013) 1.06
Lights and Shadows of Antiplatelet Therapy in Primary Percutaneous Coronary Intervention. JACC Cardiovasc Interv (2015) 1.06
The importance of echocardiography in transcatheter aortic valve implantation: TAVI: a multimodality approach. Echocardiography (2014) 1.05
Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention--effects on soluble CD40 ligand concentrations. Atherosclerosis (2009) 1.04
Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol (2003) 0.97
Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem (2004) 0.93
Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction. Am J Cardiol (2011) 0.92
Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study. J Am Coll Cardiol (2011) 0.92
Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease. Atherosclerosis (2008) 0.91
Neutrophil count and infarct size in patients with acute myocardial infarction. Int J Cardiol (2004) 0.90
Pseudoaneurysm complicating aortic coarctation in a pregnant woman. Int J Cardiol (2004) 0.88
Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: evidence for an association to haplogroup H. Mitochondrion (2010) 0.88
Atrioventricular conduction disturbance characterization in transcatheter aortic valve implantation with the CoreValve prosthesis. Circ Cardiovasc Interv (2011) 0.87
A comparative study of markers of inflammation for the assessment of cardiovascular risk in patients presenting to the emergency department with acute chest pain suggestive of acute coronary syndrome. Int J Cardiol (2005) 0.84
Usefulness of intraplatelet melatonin levels to predict angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol (2010) 0.81
Real incidence of diabetes mellitus in a coronary disease population. Am J Cardiol (2012) 0.81
Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention. Eur Heart J (2009) 0.81
Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population. Coron Artery Dis (2009) 0.81
Role of neopterin in cardiovascular medicine. Rev Esp Cardiol (2009) 0.81
The role of melatonin in acute myocardial infarction. Front Biosci (Landmark Ed) (2012) 0.80
[Comparison of echocardiographic studies made with new portable devices to conventional studies]. Rev Esp Cardiol (2003) 0.80
Neopterin--a forgotten biomarker. J Am Coll Cardiol (2003) 0.79
Long-term follow up of atrioventricular block in transcatheter aortic valve implantation. Am J Cardiol (2011) 0.79
Lack of association between endothelin-1 gene variants and myocardial infarction. J Atheroscler Thromb (2009) 0.79
[Aortic valve replacement in octogenarians with severe aortic stenosis. Experience in a series of consecutive patients at a single center]. Rev Esp Cardiol (2007) 0.79
Global left ventricular longitudinal strain is associated with decreased melatonin levels in patients with acute myocardial infarction: a two-dimensional speckle tracking study. Biomarkers (2013) 0.79
Results of fractional flow reserve measurement to evaluate nonculprit coronary artery stenoses in patients with acute coronary syndrome. Rev Esp Cardiol (Engl Ed) (2011) 0.78
Neutrophil count and complex lesions in patients with coronary artery disease. Arterioscler Thromb Vasc Biol (2005) 0.78
Neopterin: still a forgotten biomarker. Clin Chem (2005) 0.78
[Comparison of drug-eluting and bare metal stents in saphenous vein grafts. Immediate and long-term results]. Rev Esp Cardiol (2009) 0.78
Axillary approach for transcatheter aortic valve implantation: optimization of the endovascular treatment for the aortic valve stenosis. Rev Esp Cardiol (2011) 0.78
[Atherosclerotic coronary artery disease: usefulness of C-reactive protein for the identification of the vulnerable plaque and the vulnerable patient]. Rev Esp Cardiol (2004) 0.78
Neopterin predicts left ventricular remodeling in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Atherosclerosis (2010) 0.78
[Ethical considerations in the publication of scientific articles]. Rev Esp Cardiol (2011) 0.77
Neopterin and cardiovascular disease: growing evidence for a role in patient risk stratification. Clin Chem (2009) 0.77
[2011 annual summary. Another meeting with our readers]. Rev Esp Cardiol (2011) 0.77
Inflammatory markers in blood and thrombus aspirated from patients with acute myocardial infarction with st-segment elevation: ARTERIA trial study design and rationale. Biomarkers (2013) 0.77
The Ibero-American transcatheter aortic valve implantation registry with the CoreValve prosthesis. Early and long-term results. Int J Cardiol (2013) 0.77
Cardiopulmonary exercise testing for the assessment of exercise capacity in patients with cardiac syndrome X. Int J Cardiol (2011) 0.76
Drug eluting stents may not be the answer for myocardial bridges. Int J Cardiol (2007) 0.76
Aortic stenosis and porcelain aorta: could percutaneous valve implantation be a valid therapeutic option? Rev Esp Cardiol (Engl Ed) (2012) 0.76
Sudden death in a patient with multiple left anterior descending coronary artery fistulas to the left ventricle. Int J Cardiol (2007) 0.76
Elevation of high-sensitivity cardiac troponin T and composite end points in randomized trials. Am Heart J (2010) 0.75
[New statistical methods in cardiovascular research]. Rev Esp Cardiol (2011) 0.75
Left main stenting: don't forget the angiographic follow-up! EuroIntervention (2011) 0.75
Air pollution and heart failure: Relationship with the ejection fraction. World J Cardiol (2013) 0.75
C-reactive protein predicts functional status and correlates with left ventricular ejection fraction in patients with chronic stable angina. Atherosclerosis (2008) 0.75
What's up with neopterin in cardiovascular pathophysiology? Int J Cardiol (2013) 0.75
Rotational atherectomy with drug-eluting stents: a necessary technique in the current era. Catheter Cardiovasc Interv (2011) 0.75
Prognostic usefulness of C-reactive protein: importance of the diurnal variation. Am J Cardiol (2013) 0.75
Neopterin and coronary artery disease. J Cardiol (2009) 0.75
Multiple complex stenoses and chronic stable angina pectoris. Int J Cardiol (2004) 0.75
Cobalt-chromium stents in long lesions of large vessels: clinical and angiographic results. Tex Heart Inst J (2011) 0.75
Macrophage/monocyte activation and cardiovascular disease. Int J Cardiol (2012) 0.75
Vessel diameter should be taken into account in saphenous stenting. EuroIntervention (2010) 0.75
Microvascular angina due to microvascular coronary vasospasm. Int J Cardiol (2005) 0.75
Myocardial infarction in saphenous percutaneous intervention: are we really doing our best? Am Heart J (2009) 0.75
Reperfusion in acute myocardial infarction: should the guidelines be modified? JACC Cardiovasc Interv (2010) 0.75
Letter by Lozano et al regarding article, "Adjunctive thrombectomy for acute myocardial infarction: a bayesian meta-analysis". Circ Cardiovasc Interv (2010) 0.75
The dilemma of surgical or percutaneous approach in aortic stenosis: a reliable risk score is needed. Am Heart J (2010) 0.75
Escalating Loading Dose Regimens of Ticagrelor in Primary Percutaneous Intervention: A Second Opportunity for IIb/IIIa Inhibitors? JACC Cardiovasc Interv (2016) 0.75
Stent implantation in saphenous vein grafts. Am J Cardiol (2009) 0.75
SYNTAX score and left main stenting: do we need clinical variables to predict outcomes? Am Heart J (2010) 0.75
Anomalous origin of circumflex coronary artery arising from proximal right coronary artery. Int J Cardiol (2005) 0.75
Response to N P Curzen's: Is there evidence for prognostic benefit following PCI in stable patients? COURAGE and its implications: an interventionalist's view. Heart (2010) 0.75
Radial Artery in Breast Cancer Survivors: A Possible Choice but Always With Caution. JACC Cardiovasc Interv (2015) 0.75
The difficult challenge of assessing the clinical status of octogenarians with severe aortic stenosis. Am J Cardiol (2010) 0.75
Direct stenting should be attempted by default whenever possible. Heart (2010) 0.75
Neopterin - marker of coronary artery disease activity or extension in patients with chronic stable angina? Int J Cardiol (2009) 0.75